Understanding the pathophysiology of multiple sclerosis and the development of new therapies
touchTALKS for touchIMMUNOLOGY
Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifying therapies, and reviews the mechanism of action and clinical trial landscape for Bruton’s tyrosine kinase inhibitors.
The expert
Prof. Tobias Derfuss, University Hospital Basel, Switzerland
This…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.